 |
|
Restless Legs Syndrome Prevalence and Impact
REST General Population Study
Richard P. Allen, PhD;
Arthur S. Walters, MD;
Jacques Montplaisir, MD, PhD;
Wayne Hening, MD, PhD;
Andrew Myers, PhD;
Timothy J. Bell, PhD;
Luigi Ferini-Strambi, MD
Arch Intern Med. 2005;165:1286-1292.
Background Restless legs syndrome (RLS), a common sensorimotor disorder, has a wide range of severity from merely annoying to affecting sleep and quality of life severely enough to warrant medical treatment. Previous epidemiological studies, however, have failed to determine the prevalence of those with clinically significant RLS symptoms and to examine the life effects and medical experiences of this group.
Methods A total of 16 202 adults (aged  18 years) were interviewed using validated diagnostic questions to determine the presence, frequency, and severity of RLS symptoms; respondents reporting RLS symptoms were asked about medical diagnoses and the impact of the disorder and completed the Short Form-36 Health Survey (SF-36). Criteria determined by RLS experts for medically significant RLS (frequency at least twice a week, distress at least moderate) defined "RLS sufferers" as a group most likely to warrant medical treatment.
Results In all, 15 391 fully completed questionnaires were obtained; in the past year, RLS symptoms of any frequency were reported by 1114 (7.2%). Symptoms occurred at least weekly for 773 respondents (5.0%); they occurred at least 2 times per week and were reported as moderately or severely distressing by 416 (2.7%). Of those 416 (termed RLS sufferers), 337 (81.0%) reported discussing their symptoms with a primary care physician, and only 21 (6.2%) were given a diagnosis of RLS. The SF-36 scores for RLS sufferers were significantly below population norms, matching those of patients with other chronic medical conditions.
Conclusion Clinically significant RLS is common (prevalence, 2.7%), is underdiagnosed, and significantly affects sleep and quality of life.
Author Affiliations: Department of Neurology, The Johns Hopkins University, Baltimore, Md (Dr Allen); New Jersey Neuroscience Institute at JFK Medical Center, Edison, and School of Graduate Medical Education, Seton Hall University, South Orange, NJ (Dr Walters); Departments of Psychiatry and Neurosciences, Université de Montréal, Montreal, Quebec (Dr Montplaisir); Department of Neurology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick (Dr Hening); Premark Services Ltd, Crawley Down, West Sussex, England (Dr Myers); Health Solutions, Research Triangle Institute, Research Triangle Park, NC (Dr Bell); and Department of Neurosciences, Università Vita–Salute San Raffaele, Milan, Italy (Dr Ferini-Strambi). Dr Bell is now with the Gastrointestinal Research and Development Group of GlaxoSmithKline, Research Triangle Park.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome
Astrakas et al.
Neurology 2008;71:911-916.
ABSTRACT
| FULL TEXT
Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial
Hornyak et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:823-825.
ABSTRACT
| FULL TEXT
Sleep Disturbance in Bipolar Disorder: Therapeutic Implications
Plante and Winkelman
Am. J. Psychiatry 2008;165:830-843.
ABSTRACT
| FULL TEXT
Effect of Nonergot Dopamine Agonists on Symptoms of Restless Legs Syndrome
Baker et al.
Ann Fam Med 2008;6:253-262.
ABSTRACT
| FULL TEXT
Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage
Manconi et al.
Mult Scler 2008;14:86-93.
ABSTRACT
Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study
Winkelman et al.
Neurology 2008;70:35-42.
ABSTRACT
| FULL TEXT
Periodic Limb Movements in Sleep -- Endophenotype for Restless Legs Syndrome?
Winkelman
NEJM 2007;357:703-705.
FULL TEXT
Restless Legs Syndrome: Prevalence and Impact in Children and Adolescents The Peds REST Study
Picchietti et al.
Pediatrics 2007;120:253-266.
ABSTRACT
| FULL TEXT
Sleep Problems in Primary Care: A North Carolina Family Practice Research Network (NC-FP-RN) Study
Alattar et al.
J Am Board Fam Med 2007;20:365-374.
ABSTRACT
| FULL TEXT
EFFICACY AND SAFETY OF PRAMIPEXOLE IN RESTLESS LEGS SYNDROME
Kruszewski et al.
Neurology 2007;68:1641-1642.
FULL TEXT
Efficacy and safety of pramipexole in restless legs syndrome
Winkelman et al.
Neurology 2006;67:1034-1039.
ABSTRACT
| FULL TEXT
A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13.
Levchenko et al.
Neurology 2006;67:900-901.
ABSTRACT
| FULL TEXT
Sleep Disorders and Attention-Deficit Hyperactivity Disorder in Children: A Missing Differential Diagnosis
Archbold
J Am Psychiatr Nurses Assoc 2006;12:216-224.
ABSTRACT
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Cervenka et al.
Brain 2006;129:2017-2028.
ABSTRACT
| FULL TEXT
Prevalence and Correlates of Restless Legs Syndrome: Results From the 2005 National Sleep Foundation Poll
Phillips et al.
Chest 2006;129:76-80.
ABSTRACT
| FULL TEXT
Restless Legs Syndrome: Fairly Common, Very Disruptive
JWatch Psychiatry 2005;2005:9-9.
FULL TEXT
Restless Legs Syndrome: Fairly Common, Very Disruptive
Journal Watch Dermatology 2005;2005:13-13.
FULL TEXT
Restless Legs Syndrome: Fairly Common, Very Disruptive
JWatch General 2005;2005:1-1.
FULL TEXT
|
